(Q40685025)

22 September 2017

title

The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma (English)

1 reference

adaptive radiation therapy

22 September 2017

main subject

0 references

5

Nadler LM

1 reference

22 September 2017

Friedberg JW

1

1 reference

22 September 2017

Neuberg D

2

1 reference

22 September 2017

Monson E

3

1 reference

22 September 2017

Jallow H

4

1 reference

22 September 2017

Freedman AS

6

1 reference

22 September 2017

publication date

1 January 2001

1 reference

Biology of Blood and Marrow Transplantation

22 September 2017

published in

1 reference

22 September 2017

volume

7

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

446-453

1 reference

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Chemoradiotherapy for localized non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Cyclophosphamide 24 hours before or after total body irradiation: effects on lung and bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Myelodysplasia and acute leukemia after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980012-4

7 January 2021

10.1016/S1083-8791(01)80012-4

Identifiers

DOI

1 reference

22 September 2017

1 reference